Pirazzoli V, et al. (2014) Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Cell Rep 7(4):999-1008
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.